Biktarvy, formally known as biktarvy, includes a effective single-tablet therapy for controlling HIV infection. This drug combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the virus's ability to replicate within the body, considerably decreasing the viral quantity. For many indivi